相关实验视频
Updated: Jun 16, 2025

Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
大型抑郁症,双极性障碍和精神分裂症的外周免疫炎症途径:探索它们作为治疗目标的潜力
Abbas F Almulla1,2,3, Michael Maes4,5,6,7,8,9,10
1Sichuan Provincial Center for Mental Health, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.
新的研究探索了免疫系统路径和氧化应激作为主要抑郁症,双相情感障碍和精神分裂症的新药点,为治疗耐药患者提供了希望.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 重度抑郁症 (MDD),双相情感障碍 (BD) 和精神分裂症 (SCZ) 是具有高发病率的重要心理健康状况.
- 目前基于单胺的治疗方法通常是无效的,由于广泛的治疗耐药性,需要新的治疗点.
研究的目的:
- 审查免疫-炎症失调,氧化应激和相关途径作为MDD,BD和SCZ的潜在药物标.
- 突出新兴的药理学试验和针对这些途径的新治疗策略.
主要方法:
- 审查关于免疫-炎症通路,氧化和化应激 (O&NS) 和它们在精神疾病中的作用的现有文献.
- 检查重新使用的抗炎药物和针对免疫和氧化途径的新药.
- 研究肠-大脑轴和微生物组调制策略.
主要成果:
- 免疫-炎症失调和O&NS与MDD,BD和SCZ的发病有关.
- 重用药物 (COX-2 抑制剂,TNF-α 抗体,米诺环素) 和补充剂 (N-乙半氨酸,黄素,欧米茄-3 脂肪酸) 显示出作为增强疗法的希望.
- 目前正在探索肠脑轴干预措施,以恢复免疫平衡.
结论:
- 在精神疾病中,IRS/CIRS/O&NS途径代表了新药疗法的有希望的目标.
- 免疫向增强疗法在临床上很重要,与精准医学方法保持一致.
- 这些新药疗法的进一步开发得到了当前证据的支持.
更多相关视频
08:33Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
Published on: December 4, 2014
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Bipolar Disorder
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Mania and Antimanic Drugs: Overview